ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
17 announcements with these filters
Centenial Surgical Suture Ltd has appointed Ms. Sapna Mhatre as Chief Financial Officer, succeeding Ms. Anuradha Kashikar, who resigned from the position effective August 14, 2026.
Centenial Surgical Suture Ltd has filed its 31st Annual Report for the financial year 2025-2026 as per SEBI (LODR) Regulations.
Centenial Surgical Suture Ltd. has released the notice for its 31st Annual General Meeting for FY 2025-26, which is available to shareholders via its website.
Centenial Surgical Suture Ltd has announced the closure of its share transfer books from September 22 to September 28, 2026, for its 31st AGM.
Centenial Surgical Suture Ltd has appointed Ms. Sapna Mhatre as the new Chief Financial Officer. Ms. Anuradha Kashikar has resigned from the CFO position effective August 14, 2026.
Centenial Surgical Suture Ltd has appointed M/s. Utsav Shah & Associates as the internal auditor for the financial year 2026-2027.
Centenial Surgical Suture Ltd reported revenue from operations of ₹15.3 Cr (+18.6% YoY) and net profit of ₹0.7 Cr for Q1 FY27.
Centenial Surgical Suture announced Q1 financial results, CFO change, and AGM details following their August 14, 2026 board meeting.
Centenial Surgical Suture Ltd will hold a Board meeting on August 14, 2026, to consider financial results, auditor appointment, director reappointment, and AGM matters.
Mr. Sanjay Sohani has retired from his position as President - Production. He ceased to be Senior Management Personnel on June 20, 2026.
Centenial Surgical Suture Ltd reported revenue from operations of ₹12.6 Cr (-5.3% YoY) and a net loss of ₹2.3 Cr for Q4 FY26.
Centenial Surgical Suture Ltd reported annual revenue of ₹53.84 Crore for FY26. The company posted a net loss of ₹2.20 Crore for the same period.
Centenial Surgical Suture Ltd approved audited financial results for FY26 and related party transactions. The statutory auditor issued an unmodified opinion for the financial year.
Centenial Surgical Suture Ltd filed its Annual Secretarial Compliance Report for the financial year 2026. The auditor confirmed general regulatory compliance with no material penalties.
Centenial Surgical Suture Ltd scheduled a board meeting on May 30, 2026. The board will approve audited financial results for the fiscal year ended March 2026.
Centenial Surgical Suture requested BSE to investigate unusual stock price movements, alleging potential price rigging. The company denies any material changes or corporate announcements justifying the volatility.
Centenial Surgical Suture Ltd submitted its initial disclosure for FY 2026, confirming it does not qualify as a 'Large Corporate' under SEBI criteria. The company reported zero outstanding borrowings as of March 31. This regulatory filing follows mandate SEBI Circular No. SEBI/HO/DDHS/CIR/P/2018/144 regarding debt securities issuance compliance.